23andMe, Inc.
23andMe, Inc.
Explore linked clinical trials.5 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage | Disease Attributes, Nutritional and Metabolic Diseases, Parkinson disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Prodromal Stage, Prodromal Symptoms, Signs and Symptoms, basal ganglia disorder, brain disorder, central nervous system disorder, disease susceptibility, inherited disease susceptibility, metabolic disease, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, proteostasis deficiencies, synucleinopathy | Recruiting | Not applicable | 2026-08-27 | NCT06993142 | |
| Slow-SPEED-NL: Slowing Parkinson's Early Through Exercise Dosage-Netherlands | Nutritional and Metabolic Diseases, Parasomnias, Parkinson disease, Pathological Conditions, Signs and Symptoms, Prodromal Stage, Prodromal Symptoms, REM Sleep Parasomnias, REM sleep behavior disorder, Signs and Symptoms, basal ganglia disorder, brain disorder, central nervous system disorder, metabolic disease, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, proteostasis deficiencies, psychiatric disorder, sleep-wake disorder, synucleinopathy | Recruiting | Not applicable | 2026-08-27 | NCT06193252 | |
| Digital Lifestyle Coaching for Alzheimer's Disease Prevention in APOE4 Carriers | Alzheimer disease, Cognition Disorders, Cognitive Dysfunction, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Not yet recruiting | Not applicable | 2026-06-12 | NCT07646054 | |
| Study of the Safety and Effectiveness of GSK6097608 in Participants With Advanced Solid Tumors | neoplasm | Active, not recruiting | Phase 1 | 2025-10-27 | NCT04446351 | |
| A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies | Adnexal Diseases, Carcinoma, Ovarian Epithelial, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, bronchial neoplasm, bronchogenic carcinoma, carcinoma, clear cell renal carcinoma, endocrine system disorder, epithelial neoplasm, fallopian tube cancer, fallopian tube disorder, fallopian tube neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, kidney cancer, kidney disorder, lung disorder, lung neoplasm, malignant endocrine neoplasm, neoplasm, neuroendocrine neoplasm, ovarian cancer, ovarian disorder, primary peritoneal carcinoma, primitive neuroectodermal tumor, renal cell carcinoma, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma, urinary system disorder | Active, not recruiting | Phase 1 / Phase 2 | 2024-11-15 | NCT05199272 |